Helicobacter Pylori (H-Pylori) Non-Invasive Testing Market Overview:
Projected CAGR for the H. Pylori Non-Invasive Testing market is a modest 3.9% during the forecast period (2020-2026). Helicobacter Pylori infection, or H. Pylori, is the most prevalent bacterial infection, affecting the digestive tract and inner stomach lining. H. Pylori affects more than half of the world’s population. According to clinical findings, H. Pylori infection is the most prominent cause of dyspepsia, peptic ulcers and gastric adenocarcinoma.
Over the years, the incidence of H. Pylori infection has been declining. Adoption of non-invasive tests for diagnosing H. Pylori infection and subsequent treatment is rising among healthcare professionals. Availability of new and advanced non-invasive tests such as real-time PCR and Chemiluminescence Immunoassay (CLIA) are anticipated to leverage market prospects.
Helicobacter Pylori (H-Pylori) Non-Invasive Testing Market Test-type Insights:
The urea breath test segment is set to capture a majority of the global H. Pylori Non-Invasive Testing market, pegged at more than two-fifth of the overall market. Excellent clinical sensitivity and high accuracy in detecting h. pylori are anticipated to boost market prospects. Projections have pegged the urea breath segment’s CAGR at 8.2% during the forecast period. The urea breath test is also useful for evaluation of post-treatment status.
Stool Antigen Tests are poised to account for the second-highest proportion of H. Pylori Non-invasive testing in the future. The simplicity and effectiveness in detecting bacteria are key drivers anticipated to raise the market prospects. The Stool Antigen Test segment shall account for more than 40% of the total H. Pylori Non-invasive testing market, expanding at a CAGR of 2.5%.
-non-invasive-treatment-market-01.jpg "Global Helicobacter Pyroli (h.pyroli) Non Invasive Treatment Market 01")
To get intuitive insights on the helicobacter pylori (h-pylori) non-invasive testing market, ask an analyst here
Helicobacter Pylori (H-Pylori) Non-Invasive Testing Market Regional Insights:
North America is set to be the kingpin of the global H. Pylori testing market. This is attributed to changing healthcare reforms and implementation of guidelines by healthcare agencies regarding non-invasive testing of H. Pylori. These policies have redirected healthcare organizations and professionals to concentrate more on urea based testing and stool antigen tests. This is because serology tests, the main type of test to detect presence of H. Pylori, provide false positive predicted value and cannot distinguish between current or past infections. In the wake of this, the North American market shall account for more than three-tenths of the global H. Pylori Testing Market.
-non-invasive-treatment-market-02.jpg "Global Helicobacter Pyroli (h.pyroli) Non Invasive Treatment Market 02")
To get the latest COVID-19 impact insights on the helicobacter pylori (H.Pylori) non-invasive testing market, request for a report sample here
Following North America is Asia-Pacific, poised to be leveraged moderately at a CAGR of 4.5%. Improvement in public health and creation of awareness are anticipated to contain the rate of H. Pylori infections during the forecast period. Testing for H. Pylori infection in communities with high incidence of gastric cancer is increasing, thus preventing further cases. More than one-fifth of the global H. Pylori testing market shall be held by the Asia-Pacific region.
Helicobacter Pylori (H-Pylori) Non-Invasive Testing Market Manufacturers
The global H. Pylori non-invasive testing market comprises of the following market players: Meridian Bioscience, Inc., DiaSorin S.p.A, Alere, Sekiusi Diagnostics and Biomerica, Inc. Besides these, a host of other players have a significant market presence as well. These are Biohit Oyj, Exalenz Bioscience Ltd., Aalto Bio Reagents Ltd., Certest Biotec S.L. and CorisBioconcept SPRL.
Meridian Bioscience, Inc. markets its tests and assay kits to hospitals, reference laboratories and other diagnostic manufacturers in more than 60 countries. Its H. Pylori testing products include the Premium Platinum HpSA PLUS or Premium H. Pylori. It is an in vitro qualitative procedure to detect the presence of H. Pylori bacteria in the human stool.
Exalenz Biosciences manufactures the H. Pylori IgG ELISA Kit, BreathID HP, BreathID Smart and Breath ID Lab devices. These devices conduct a quick and accurate Urea Breath Test for diagnosing H. Pylori infection and confirming post-treatment eradication. The test is conducted in real-time by continuously sampling breath, eliminating the need for sample collection, labeling, transport and analysis.
COVID-19 Market Insights:
Although there is a dearth of evidence suggesting any links between the COVID-19 and H. Pylori infections, experts have concluded that patients need to be provided treatment on a priority basis. This is because the COVID-19 infection affects the gastrointestinal tract, inducing nausea, vomiting and diarrhea. Since H. Pylori primarily infects the GI tract, it is important for those patients to be provided immediate medical attention if infected with the COVID-19. As the pandemic is spreading at an exponential rate, key manufacturers are accelerating their efforts to contain its spread.
This involves redirecting their resources towards developing COVID-19 testing kits. For instance, Meridian Bioscience has launched the QuickPac II 2019 COVID-19 IgG and IgM qualitative testing kit for the detection of potential antibodies to combat the novel coronavirus strain in the human serum, plasma or blood. Similarly, DiaSorin S.p.A announced the launch of its LIAISON SARS CoV-2 S1/S2 IgG serological test. Such developments are anticipated to shift focus away from H. Pylori testing, leading to a dip in its demand. However, patients requiring urgent care will be provided with the appropriate treatment.
Analyst’s Viewpoint:
The global H. Pylori non-invasive testing systems market shall record modest growth. Although the incidence of testing has burgeoned, the asymptomatic nature of the infection has limited its diagnosis. This is majorly responsible for the market’s moderate growth trajectory. Moreover, the ongoing coronavirus pandemic is anticipated to shift focus on eradicating the current disease, leading to a dip in h. pylori testing.
Global H. Pylori Non-Invasive Testing Market: Report Scope:
The recent report published by Fact.MR incorporates a six-year forecast period, ranging from 2020 to 2026, and elaborates on the key drivers, opportunities and restraints associated with the H. Pylori non-invasive testing systems market. The study includes a detailed analysis of key segments’ revenue, market share and growth across the forecast period. The global h. pylori non-invasive testing systems market has been segmented based on non-invasive test type, test method and end-user.
An elaborate regional landscape has also been provided. This section incorporates an analysis of the abovementioned segments across North America, Europe, Asia-Pacific, Latin America and Middle East & Africa. In addition, a section on competitive landscape has also been embedded within the report. This part highlights key companies’ profiles, their revenue and market shares, key collaborations, product launches and SWOT analysis in order to provide a realistic picture about their future prospects.
Global Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market- Scope of the Report
The recent study by Fact.MR on global helicobacter pylori (h. pylori) Non-invasive testing market offers a 6-year forecast between 2020 and 2026. The study analyzes crucial trends that are currently determining the growth of global helicobacter pylori (h. pylori) Non-invasive testing market. This report explicates on vital dynamics such as the drivers, restraints and opportunities for key market players along with key stakeholders as well as emerging players associated with the provision of helicobacter pylori (h. pylori) Non-invasive testing. The study also provides dynamics that are responsible for influencing the future status of the global helicobacter pylori Non-invasive testing market over the forecast period.
A detailed assessment of the global helicobacter pylori (h. pylori) Non-invasive testing market value chain analysis, business execution, and supply chain analysis across the regional markets has been covered in the report. A list of prominent companies operating in the global helicobacter pylori (h. pylori) Non-invasive testing market along with their product portfolio enhances the reliability of this comprehensive research study.
Global Helicobacter Pylori (H. Pylori) Non-invasive testing Market: Report Summary
The study offers a comprehensive analysis on diverse features including production capacities, demand, product developments, revenue generation and sales in global helicobacter pylori (h. pylori) Non-invasive testing market across the globe.
A comprehensive estimate of the global helicobacter pylori (h. pylori) Non-invasive testing market has been provided through an optimistic as well as a conservative scenario, taking into account the sales of the global helicobacter pylori (h. pylori) Non-invasive testing market during the forecast period. Price point comparison by region with global average price is also considered in the study.
Global Helicobacter Pylori (H. Pylori) Non-invasive testing: Market Segmentation
Fact.MR has studied the global helicobacter pylori (h. pylori) Non-invasive testing market with detailed segmentation on the basis of Non-invasive Test Type, Test Method, End-user and key regions.
|
Non-invasive Test Type |
Test Type |
End-user |
Key Regions |
|
Serology Test |
Laboratory-based Tests |
Hospitals |
North America |
|
Stool Antigen Test |
Point-of-Care Tests |
Diagnostic Labs |
Europe |
|
Urea Breath Test |
|
Clinics |
Asia Pacific |
|
|
|
|
Latin America |
|
|
|
|
Middle East & Africa (MEA) |
“This taxonomy prepared is confidential and intended exclusively for the individual or entity with whom it is being shared. Reading, disseminating, distributing, or copying this to any party other than addressee(s) is unauthorized and prohibited.”
Global Helicobacter Pylori (H. Pylori) Non-invasive testing Market: Analysis on Market Size Evaluation
The global helicobacter pylori (h. pylori) Non-invasive testing market has been analyzed for each market segment, in terms of value (US$ Mn).
Market estimates at global and regional levels for helicobacter pylori (h. pylori) Non-invasive testing is available in terms of “US$ Mn” for value. A Y-o-Y growth contrast on prominent guidewire market segments, along with market attractiveness evaluation has been incorporated in the report.
Global Helicobacter Pylori (H. Pylori) Non-invasive testing Market: Inspected Assessment on Regional Segments
Key sections have been elaborated in the global helicobacter pylori (h. pylori) Non-invasive testing report, which have helped to deliver projection on the regional markets. These chapters include the regional macros (economic, and business environment outlook), which are expected to have a momentous influence on the growth of the global helicobacter pylori (h. pylori) Non-invasive testing market during the forecast period.
Country-specific valuation on demand for helicobacter pylori (h. pylori) Non-invasive testing has been offered for each regional market, along with the market scope, estimate and forecast, price index, and impact analysis of dynamics of prominence in regions and countries. For all regional markets, Y-o-Y growth estimates have also been incorporated in the report.
Global Helicobacter Pylori (H. Pylori) Non-invasive testing Market: In-Depth Analysis on Competitive Landscape
The report sheds light on the leading manufacturers of global helicobacter pylori (h. pylori) Non-invasive testing along with their detailed profiles. Essential and up-to-date data information related to the market performers, who are principally engaged in the provision of global helicobacter pylori (h. pylori) Non-invasive testing, has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permits the report readers to take preemptive steps in advancing their businesses.
Company profiles have been included in the report, which includes essentials such as product portfolio, key strategies along with all-inclusive SWOT analysis on each player. Company presence is mapped and presented through the matrix for all the prominent players thus providing the readers with actionable insights, which helps in thoughtfully presenting market status, and predicting the competition level in the global helicobacter pylori (h. pylori) Non-invasive testing market. Prominent manufacturers with established market presence in the global helicobacter pylori (h. pylori) Non-invasive testing market are Meridian Bioscience, Inc., DiaSorin S.p.A, Alere, Sekiusi Diagnostics and Biomerica, Inc.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Acronyms Used
3. Research Methodology
4. Executive Summary
5. Market Overview
5.1. Test Type Overview
5.2. Market Dynamics
5.2.1. Drivers
5.2.2. Restraints
5.2.3. Opportunities
5.3. Global Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market Value (US$ Mn) Forecast, 2020-2026
5.4. Global Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market Outlook
5.5. Key Industry Developments
5.6. Epidemiological Assessment of Helicobacter Pylori
5.7. New Non-invasive H. Pylori Test launches, by Market Players
5.8. Key Technological Advancements in Helicobacter Pylori Diagnostic Testing
6. Global Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market Analysis, by Test Type
6.1. Introduction
6.2. Key Findings
6.3. Global Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market Value Share Analysis, by Test Type
6.4. Global Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market Value Forecast, by Test Type, 2020-2026
6.4.1.1. Serology Test
6.4.1.2. Stool Antigen Test (SAT)
6.4.1.3. Urea Breath Test (UBT)
6.4.2. Endoscopy Helicobacter Pylori (H. Pylori) Non-Invasive Testing Test Types
6.5. Global Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market Attractiveness, by Test Type, 2020–2026
7. Global Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market Analysis, by Test Method
7.1. Introduction
7.2. Key Findings
7.3. Market Value Share Analysis, by Test Method
7.4. Market Value Forecast, by Test Method, 2020–2026
7.4.1. Laboratory-based Tests
7.4.2. Point-of-Care Tests
7.5. Market Attractiveness, by Test Method
8. Global Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market Analysis, by End-user
8.1. Introduction
8.2. Key Findings
8.3. Market Value Share Analysis, by End-user
8.4. Market Value Forecast, by End-user, 2020–2026
8.4.1. Hospitals
8.4.2. Clinics
8.4.3. Diagnostic Laboratories
8.5. Market Attractiveness, by End-user
9. Global Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market Analysis and Forecasts, by Region
9.1. Introduction
9.2. Regional Outlook
9.3. Global Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market Value Forecast, by Region, 2020–2026
9.3.1. North America
9.3.2. Europe
9.3.3. Asia Pacific
9.3.4. Latin America
9.3.5. Middle East & Africa
9.4. Global Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market Attractiveness Analysis, by Region
10. North America Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market Analysis
10.1. Key Findings
10.2. North America Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market Value Forecast, by Country, 2020-2026
10.2.1. U.S.
10.2.2. Canada
10.3. North America Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market Value Forecast, by Test Type, 2020–2026
10.3.1. Serology Test
10.3.2. Stool Antigen Test (SAT)
10.3.3. Urea Breath Test (UBT)
10.4. North America Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market Value Forecast, by Test Method, 2020–2026
10.4.1. Laboratory-based Tests
10.4.2. Point-of-Care Tests
10.5. North America Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market Value Forecast, by End-user, 2020–2026
10.5.1. Hospitals
10.5.2. Clinics
10.5.3. Diagnostic Laboratories
10.6. North America Market Attractiveness Analysis
10.6.1. By Country
10.6.2. By Test Type
10.6.3. By Test Method
10.6.4. By End-user
11. Europe Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market Analysis
11.1. Key Findings
11.2. Europe Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market Value Forecast by Country/Sub-region, 2020-2026
11.2.1. Germany
11.2.2. U.K.
11.2.3. France
11.2.4. Italy
11.2.5. Spain
11.2.6. Rest of Europe
11.3. Europe Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market Value Forecast, by Test Type, 2020–2026
11.3.1. Serology Test
11.3.2. Stool Antigen Test (SAT)
11.3.3. Urea Breath Test (UBT)
11.3.4. Endoscopy Helicobacter Pylori (H. Pylori) Non-Invasive Testing Test Types
11.4. Europe Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market Value Forecast, by Test Method, 2020–2026
11.4.1. Laboratory-based Tests
11.4.2. Point-of-Care Tests
11.5. Europe Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market Value Forecast, by End-user, 2020–2026
11.5.1. Hospitals
11.5.2. Clinics
11.5.3. Diagnostic Laboratories
11.6. Europe Market Attractiveness Analysis
11.6.1. By Country/Sub-region
11.6.2. By Test Type
11.6.3. By Test Method
11.6.4. By End-user
12. Asia Pacific Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market Analysis
12.1. Key Findings
12.2. Asia Pacific Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market Value Forecast by Country/Sub-region, 2020-2026
12.2.1. China
12.2.2. India
12.2.3. Japan
12.2.4. Australia
12.2.5. Rest of Asia Pacific
12.3. Asia Pacific Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market Value Forecast, by Test Type, 2020–2026
12.3.1. Serology Test
12.3.2. Stool Antigen Test (SAT)
12.3.3. Urea Breath Test (UBT)
12.3.4. Endoscopy Helicobacter Pylori (H. Pylori) Non-Invasive Testing Test Types
12.4. Asia Pacific Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market Value Forecast, by Test Method, 2020–2026
12.4.1. Laboratory-based Tests
12.4.2. Point-of-Care Tests
12.5. Asia Pacific Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market Value Forecast, by End-user, 2020–2026
12.5.1. Hospitals
12.5.2. Clinics
12.5.3. Diagnostic Laboratories
12.6. Asia Pacific Market Attractiveness Analysis
12.6.1. By Country/Sub-region
12.6.2. By Test Type
12.6.3. By Test Method
12.6.4. By End-user
13. Latin America Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market Analysis
13.1. Key Findings
13.2. Latin America Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market Value Forecast by Country/Sub-region, 2020-2026
13.2.1. Brazil
13.2.2. Mexico
13.2.3. Rest of Latin America
13.3. Latin America Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market Value Forecast, by Test Type, 2020–2026
13.3.1. Serology Test
13.3.2. Stool Antigen Test (SAT)
13.3.3. Urea Breath Test (UBT)
13.3.4. Endoscopy Helicobacter Pylori (H. Pylori) Non-Invasive Testing Test Types
13.4. Latin America Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market Value Forecast, by Test Method, 2020–2026
13.4.1. Laboratory-based Tests
13.4.2. Point-of-Care Tests
13.5. Latin America Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market Value Forecast, by End-user, 2020–2026
13.5.1. Hospitals
13.5.2. Clinics
13.5.3. Diagnostic Laboratories
13.6. Latin America Market Attractiveness Analysis
13.6.1. By Country/Sub-region
13.6.2. By Test Type
13.6.3. By Test Method
13.6.4. By End-user
14. Middle East & Africa Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market Analysis
14.1. Key Findings
14.2. Middle East & Africa Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market Value Forecast by Country/Sub-region, 2020-2026
14.2.1. GCC Countries
14.2.2. Israel
14.2.3. South Africa
14.2.4. Rest of Middle East & Africa
14.3. Middle East & Africa Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market Value Forecast, by Test Type, 2020–2026
14.3.1. Serology Test
14.3.2. Stool Antigen Test (SAT)
14.3.3. Urea Breath Test (UBT)
14.3.4. Endoscopy Helicobacter Pylori (H. Pylori) Non-Invasive Testing Test Types
14.4. Middle East & Africa Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market Value Forecast, by Test Method, 2020–2026
14.4.1. Laboratory-based Tests
14.4.2. Point-of-Care Tests
14.5. Middle East & Africa Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market Value Forecast, by End-user, 2020–2026
14.5.1. Hospitals
14.5.2. Clinics
14.5.3. Diagnostic Laboratories
14.6. Middle East & Africa Market Attractiveness Analysis
14.6.1. By Country/Sub-region
14.6.2. By Test Type
14.6.3. By Test Method
14.6.4. By End-user
15. Competitive Landscape
15.1. Competition Matrix
15.2. Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market Share Analysis, by Company, 2018
15.3. Company Profiles
15.3.1. DiaSorin S.p.A.
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Financial Overview
15.3.1.3. Test Type Portfolio
15.3.1.4. SWOT Analysis
15.3.1.5. Strategic Overview
15.3.2. Meridian Bioscience, Inc.
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Financial Overview
15.3.2.3. Test Type Portfolio
15.3.2.4. SWOT Analysis
15.3.2.5. Strategic Overview
15.3.3. Exalenz Bioscience Ltd.
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Financial Overview
15.3.3.3. Test Type Portfolio
15.3.3.4. SWOT Analysis
15.3.3.5. Strategic Overview
15.3.4. Alere
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Test Type Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Strategic Overview
15.3.5. Thermo Fisher Scientific
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Financial Overview
15.3.5.3. Test Type Portfolio
15.3.5.4. SWOT Analysis
15.3.5.5. Strategic Overview
15.3.6. Biomerica, Inc.
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Financial Overview
15.3.6.3. Test Type Portfolio
15.3.6.4. SWOT Analysis
15.3.6.5. Strategic Overview
15.3.7. Certest Biotec S.L.
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Financial Overview
15.3.7.3. Test Type Portfolio
15.3.7.4. SWOT Analysis
15.3.7.5. Strategic Overview
15.3.8. Sekisui Diagnostics
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Test Type Portfolio
15.3.8.3. SWOT Analysis
15.3.9. CorisBioconcept SPRL
15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2. Test Type Portfolio
15.3.9.3. SWOT Analysis
15.3.10. Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd.
15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.10.2. Test Type Portfolio
15.3.10.3. SWOT Analysis
Fact.MR offers custom research services that help clients to get specific research solutions
Related reports
We are committed towards customer satisfaction and quality service.
Helicobacter Pylori (H-Pylori) Non-Invasive Testing Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2020 to 2026